We are a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system,or CNS, disorders. We were founded by globally recognized leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. Our principal executive offices are located in Redwood City, California.
